Press Releases

Press Releases

Retractable Technologies, Inc. Reports Results for 2023

LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2023. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 29, 2024 with the U.S. Securities and

Read More »
Press Releases

Safety Communication from FDA Is Not Related to Vanishpoint® Syringe

You may have heard about the November 30, 2023 FDA Safety Communication, “Evaluating Plastic Syringes Made in China for Potential Device Failures.” Retractable Technologies Inc. wants to assure you that the safety communication does not refer or relate to VanishPoint safety syringes from Retractable Technologies. The FDA identified quality issues

Read More »
Press Releases

Retractable Technologies, Inc. Announces Reduction in Workforce

Retractable Technologies, Inc. Announces Reduction in Workforce LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 16% as a result of the substantial completion of its facility expansion efforts and the completion of U.S. government orders to provide its products

Read More »
Press Releases

Retractable Technologies, Inc. Announces Termination of Buyback Plan

Retractable Technologies, Inc. Announces Termination of Buyback Plan LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) reports that, effective April 14, 2022, it has terminated its Rule 10b5-1/10b-18 Repurchase Plan dated June 4, 2021. Since June 2021, Retractable has purchased a total of 1,087,145 shares for approximately $8.1

Read More »